CD19 and Miyoshi myopathy: The aim of the study was an analysis of the CD19+CD24hiCD38hi Bregs’ frequency in the MM patients and Ps patients as well as the comparison of CD19+CD24hiCD38hi Bregs’ frequency in the patients with RRMM before and after daratumumab treatment.